Cutera logo
Cutera CUTR
report update icon

Quarterly report 2024-Q3
added 05-30-2026

Cutera Net Income | CUTR

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Cutera

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
-57.2 M -7.79 M 2.06 M -23.9 M -12.3 M -30.8 M 30 M 2.58 M -4.44 M -10.6 M -4.75 M -6.55 M -10.1 M -10.5 M -17.7 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
30 M -57.2 M -10.8 M

Quarterly Net Income Cutera

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-39 M -24.7 M -22.8 M - -44.3 M -33.3 M -28 M - -12.1 M -47.3 M -15.1 M - -1.39 M 7.75 M -359 K 2.19 M -2.26 M -11.4 M -12.4 M -2.09 M -2.63 M 588 K -8.22 M -26.3 M -873 K -1.57 M -2.03 M 22.9 M 6.19 M 1.95 M -1.02 M 4.21 M 1.64 M -1.23 M -2.05 M 2.05 M -957 K -1.89 M -3.64 M -1.62 M -2.64 M -2.74 M -3.61 M -278 K -1.67 M -638 K -2.16 M 1.08 M -892 K -1.47 M -5.27 M -887 K -2.86 M -2.46 M -3.86 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
22.9 M -47.3 M -6.37 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Medical devices industry

Issuer Net Income Price % 24h Market Cap Country
Inogen Inogen
INGN
22.7 M $ 5.58 -1.85 % $ 148 M usaUSA
Globus Medical Globus Medical
GMED
538 M $ 70.5 0.73 % $ 9.53 B usaUSA
Quanterix Corporation Quanterix Corporation
QTRX
-107 M $ 2.07 -27.62 % $ 88.3 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
22.5 M $ 82.34 -1.33 % $ 1.05 B usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
-75 M $ 0.26 -8.45 % $ 16.8 M israelIsrael
ClearPoint Neuro ClearPoint Neuro
CLPT
-25.5 M $ 7.77 -1.21 % $ 220 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
-49.2 M $ 2.49 2.05 % $ 305 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
-9.14 K - -1.98 % $ 98.3 M usaUSA
AxoGen AxoGen
AXGN
-15.7 M $ 56.98 2.9 % $ 2.62 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
-4.44 M $ 0.5 -28.53 % $ 8.47 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
-8.2 M $ 5.1 12.83 % $ 317 M usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
-7.72 M $ 2.3 1.55 % $ 37.6 M usaUSA
Stryker Corporation Stryker Corporation
SYK
849 M $ 318.0 0.14 % $ 122 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
-517 M $ 13.87 2.32 % $ 1.06 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
19.1 M $ 26.45 1.54 % $ 605 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
-8.3 M $ 63.28 3.13 % $ 9.61 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
-242 M $ 94.44 2.74 % $ 5.15 B britainBritain
Tandem Diabetes Care Tandem Diabetes Care
TNDM
-205 M $ 16.97 -0.53 % $ 1.15 B usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
-42.6 M $ 6.87 -2.97 % $ 208 M canadaCanada
LENSAR LENSAR
LNSR
-34.3 M $ 4.91 -0.07 % $ 58.7 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
-92.2 M $ 6.59 -1.27 % $ 261 M curacaoCuracao
Pulmonx Corporation Pulmonx Corporation
LUNG
-54 M $ 2.69 -1.83 % $ 109 M usaUSA
InspireMD InspireMD
NSPR
-48.8 M $ 0.68 4.58 % $ 43.7 M israelIsrael
InMode Ltd. InMode Ltd.
INMD
93.8 M $ 12.87 -0.43 % $ 832 M israelIsrael
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
-39.6 M $ 31.67 0.81 % $ 743 M usaUSA
Outset Medical Outset Medical
OM
-81.7 M $ 3.04 -3.8 % $ 46.2 M usaUSA
PAVmed PAVmed
PAVM
-3.77 M $ 1.3 -13.91 % $ 872 K usaUSA
AVITA Medical AVITA Medical
RCEL
-48.6 M $ 16.71 5.96 % $ 466 M australiaAustralia
Sintx Technologies Sintx Technologies
SINT
-10.4 M $ 1.21 -2.42 % $ 3.36 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-14.5 M - -1.42 % $ 435 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-10.9 M - 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
-17.4 M - - $ 462 M usaUSA
Beyond Air Beyond Air
XAIR
34.3 K $ 1.84 -8.46 % $ 15.3 B usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
4.97 K $ 0.21 3.74 % $ 29.3 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
-72.3 M - - $ 955 M usaUSA
Vivos Therapeutics Vivos Therapeutics
VVOS
-21.2 M $ 0.08 -5.9 % $ 822 K usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
-70.3 M $ 18.14 0.19 % $ 751 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
-70.8 M $ 7.38 -2.06 % $ 997 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
-16.7 M - -4.14 % $ 702 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
145 M $ 58.04 -2.31 % $ 1.7 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
103 M $ 126.97 -0.01 % $ 4.41 B usaUSA
Avanos Medical Avanos Medical
AVNS
-72.9 M $ 24.99 - $ 1.16 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
53.4 M - 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
-463 M - 37.08 % $ 85.7 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
-40.9 M $ 1.62 -0.92 % $ 35.7 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
-10.9 M - 14.99 % $ 929 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
26.6 M - -0.97 % $ 54.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
8.33 M - - $ 140 M usaUSA
GBS GBS
GBS
-12.5 M - -0.57 % $ 7.12 M usaUSA